Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NOS3 |
| Upstream (Parents) |
|---|
| (<<) CDK5 → NOS3 |
| (<<) CFL2 → NOS3 |
| (<<) FAM48A → NOS3 |
| (<<) GAL → NOS3 |
| (<<) GRIN2D → NOS3 |
| (<<) ITGAV → NOS3 |
| (<<) JUND → NOS3 |
| (<<) LBX1 → NOS3 |
| (<<) LYAR → NOS3 |
| (<<) OAF → NOS3 |
| (<<) PDE4C → NOS3 |
| (<<) PRR5 → NOS3 |
| (<<) ROCK1 → NOS3 |
| (<<) RRP9 → NOS3 |
| (<<) SH2D2A → NOS3 |
| (<<) SH3TC1 → NOS3 |
| (<<) SOX18 → NOS3 |
| (<<) VAC14 → NOS3 |
| (<<) ZNF467 → NOS3 |
| Downstream (Children) |
|---|
| NOS3 → ENO2 (>>) |
| NOS3 → ENTPD7 (>>) |
| NOS3 → LGALS3 (>>) |
| NOS3 → LOC642031 (>>) |
| NOS3 → LOC92249 (>>) |
| NOS3 → MAPK6 (>>) |
| NOS3 → SDK2 (>>) |
| NOS3 → STAT5B (>>) |
